ArticleCase reports in surgery2026
Hepatocellular Carcinoma Arising From Well-Differentiated Hepatocellular Neoplasm of Uncertain Malignant Potential in a Patient With Abernethy Malformation.
Article in Case reports in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abernethy malformation is a rare congenital extrahepatic mesocaval shunt (CEMS) in which mesenteric venous blood bypasses the liver completely (type I) or partially (type II) and drains directly into the vena cava. In complete CEMS (type I), the intrahepatic portal vein is absent. The resulting lack of portal flow is associated with the development of hepatic nodules, such as focal nodular hyperplasia (FNH), hepatocellular adenoma (HCA), and hepatocellular carcinoma (HCC). These lesions have a higher risk of malignant transformation than conventional adenomas. The term hepatocellular neoplasm of uncertain malignant potential (HUMP) has been proposed for borderline lesions between HCA and well-differentiated HCC, diagnosed based on atypical histological, genetic, or clinical features suggesting a possible malignant potential. However, the exact risk of malignant transformation is unknown. We present the case of a 32-year-old man with Type I Abernethy malformation who developed malignant transformation of a HUMP over a 15-year period. Serial hepatic resections performed at other institutions demonstrated histological progression from HUMP to HCC with subsequent lung metastasis. This gradual transformation has been documented in several surgical specimens. This case highlights the need for careful recognition of HUMP in patients with Abernethy malformation, as timely liver transplantation may be essential to prevent malignant transformation and achieve curative outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.